| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $31.5M | — | -12.5% |
| SG&A Expense | $17.1M | — | -40.0% |
| Operating Income | -$48.5M | — | +24.7% |
| Interest Expense | $473K | — | +0.2% |
| Net Income | -$47.6M | — | +22.4% |
| EPS (Basic) | -$0.42 | — | +25.0% |
| EPS (Diluted) | -$0.42 | — | +25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.6M | -36.0% | -0.4% |
| Short-term Investments | $94.8M | -14.9% | -64.7% |
| Current Assets | $149.8M | -22.3% | -53.8% |
| Total Assets | $285.4M | -13.6% | -39.4% |
| Current Liabilities | $24.5M | -19.0% | -30.7% |
| Total Liabilities | $47.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$45.4M | — | +18.6% |
| Capital Expenditures | $93K | — | -74.5% |
| Investing Cash Flow | $17.4M | — | +130.1% |
| Financing Cash Flow | -$1K | — | — |
| Free Cash Flow | -$45.5M | — | +19.0% |
| -19.6% |
| Stockholders' Equity | $238.0M | -14.1% | -42.2% |